Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,941 | -3,379 | -2,663 | -10,907 | -3,407 |
| Depreciation Amortization | 7 | 8 | 15 | 675 | 3,563 |
| Accounts receivable | 7 | -3 | 17 | -14 | 7 |
| Other Working Capital | -109 | 231 | -506 | -67 | 1,895 |
| Other Operating Activity | 3,058 | 987 | -135 | 7,277 | -4,395 |
| Operating Cash Flow | $-2,978 | $-2,156 | $-3,271 | $-3,036 | $-2,337 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | 2 | N/A | 1 | -26 |
| Purchase Sale Intangibles | -78 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -78 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-82 | $2 | $0 | $1 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,950 | 1,350 | 1,648 | 1,368 | 2,595 |
| Debt Repayment | -3 | -4 | -7 | -5 | -6 |
| Common Stock Issued | N/A | N/A | 1,691 | 2,959 | 1 |
| Financing Cash Flow | $2,947 | $1,346 | $3,332 | $4,322 | $2,590 |
| Beginning Cash Position | 432 | 1,241 | 1,274 | 8 | 74 |
| End Cash Position | 318 | 432 | 1,241 | 1,274 | 8 |
| Net Cash Flow | $-114 | $-809 | $-33 | $1,266 | $-66 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,978 | -2,156 | -3,271 | -3,036 | -2,337 |
| Capital Expenditure | -4 | N/A | N/A | N/A | -26 |
| Free Cash Flow | -2,982 | -2,156 | -3,271 | -3,036 | -2,363 |